The Business Times

Eli Lilly

Consumer & Healthcare

Eli Lilly to invest US$1 billion in India contract manufacturing

White House Press Secretary Karoline Leavitt holds US President Donald Trump's letter to Eli Lilly CEO David Ricks during a press briefing at the White House in Washington, D.C., July 31, 2025.
International

Trump pressures 17 pharma CEOs to cut US drug prices

Zepbound, used to treat obesity, and Mounjaro, a diabetes drug, are in extremely high demand, with Lilly seeking to establish reliable supplies.
Consumer & Healthcare

Lilly to boost obesity drug supply with US$3 billion expansion

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
Consumer & Healthcare

Eli Lilly gets nod to launch blockbuster weight-loss drug in Hong Kong

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
Consumer & Healthcare

Eli Lilly shells out US$4.5 billion for new drug development plant

Patients who were on weekly injections showed a 94 per cent reduction in the risk of progression to type 2 diabetes, compared with placebo.
Consumer & Healthcare

Lilly's weight-loss drug cuts diabetes risk in overweight patients

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
International

Lilly agrees to buy US drugmaker Morphic in US$3.2 billion deal

Using diabetes drugs such as Ozempic for weight loss will make shortages worse, EU regulators said.
Consumer & Healthcare

Cosmetic Ozempic use under fire in Europe amid drug shortages

FILE PHOTO: FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar/File Photo
International

Lilly invests over US$5 billion to boost weight-loss drug supply

FILE PHOTO: FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar/File Photo
Companies & Markets

Lilly’s US$2.5 billion German plant will boost obesity-drug supply

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More